Trial NCT00573131

View at ClinicalTrials.gov 
Org. Study IDs: PR016-CLN-pro003

Last trial update was posted on 2022-06-22

MeSH Interventions

Cisplatin Paclitaxel

MeSH Conditions

Carcinoma, Squamous Cell Esophageal Neoplasms

Other Conditions

Adenocarcinoma of the Esophagus Esophageal Cancer Squamous Cell Carcinoma

Stopping Reasons

OncoGel did not show any impact on overall tumor response

Limitations And Caveats

Study prematurely terminated due to lack of efficacy in primary endpoint.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID